Humanized Mice for Studying Human Immune Responses and Generating Human Monoclonal Antibodies
Author:
- 14 March 2014
- journal article
- review article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 2 (2) , 157-171
Abstract
The new-generation humanized (Hu) mouse models permit multilineage human hematopoiesis and generate T cells, B cells, macrophages, and dendritic cells required for a coordinated human immune response. Therefore, any desired antigen or human-specific pathogens that can infect humanized mice can be used to generate human antibody responses. Two leading humanized mouse models are currently being used. The Hu-HSC model uses the transplantation of human hematopoietic stem cells (HSCs), whereas the BLT mouse model is created by transplantation of human fetal liver, thymus, and HSC. A number of human pathogens such as HIV-1, dengue, Epstein-Barr virus, and hepatitis C virus have been studied in these systems. Responder antigen-specific B cells from these animals can be collected and used to generate human monoclonals by B-cell immortalization or by single-cell PCR methods to “rescue” antibody-producing genes for ectopic expression. Both models generate cellular and humoral immune responses. However, the antibodies generated are primarily of the IgM type because of the inefficient immunoglobulin class switch resulting in the suboptimal production of antigen-specific affinity-matured IgG. The current Hu mouse models thus far have permitted the analysis of human “antibodyome,” and recent reports demonstrated their utility in generating human monoclonal antibodies. Ongoing efforts at further refinements are expected to make these systems more efficient in the near future.Keywords
This publication has 67 references indexed in Scilit:
- Human immune responses and potential for vaccine assessment in humanized miceCurrent Opinion in Immunology, 2013
- Modelling HIV infection and therapies in humanised miceSwiss Medical Weekly, 2012
- Humanized mice as a preclinical tool for infectious disease and biomedical researchAnnals of the New York Academy of Sciences, 2011
- The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatmentRetrovirology, 2011
- Molecular engineering and design of therapeutic antibodiesCurrent Opinion in Immunology, 2008
- NOD/Shi-scid IL2rγnull (NOG) Mice More Appropriate for Humanized Mouse Models2008
- From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic miceNature Biotechnology, 2007
- Human antibodies from transgenic animalsNature Biotechnology, 2005
- Human Xenograft Models for Virus InfectionVirology, 2000
- Development and applications of the SCID-hu mouse modelSeminars in Immunology, 1996